Search research articles
Contact Us
Filters
Showing results (71-80 of 250) with videos related to
Page
of 25
Sort By:
Cancer Research
|
August 1, 1987
Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin
B Barbieri, F C Giuliani, T Bordoni, et al.
Anticancer Research
|
September 1, 1986
DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs
S Spadari, G Pedrali-Noy, F Focher, et al.
Journal of Medicinal Chemistry
|
April 1, 1989
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives
F M Arcamone, F Animati, B Barbieri, et al.
Fitoterapia
|
July 5, 2016
Phytochemistry, micromorphology and bioactivities of Ajuga chamaepitys (L.) Schreb. (Lamiaceae, Ajugoideae): Two new harpagide derivatives and an unusual iridoid glycosides pattern
A Venditti, C Frezza, F Maggi, et al.
Molecular Pharmacology
|
July 1, 1995
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives
P De Isabella, M Palumbo, C Sissi, et al.
Journal of Endocrinological Investigation
|
December 4, 2009
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters
A Di Mambro, C Giuliani, F Ammannati, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
May 14, 2020
How is small bowel permeability in endometriosis patients? a case control pilot study
D ViganĂ³, F Zara, S Pinto, et al.
Journal of Endocrinological Investigation
|
November 13, 2007
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells
S Benvenuti, I Cellai, P Luciani, et al.
Biochemical Pharmacology
|
January 24, 1997
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenediones
P de Isabella, M Palumbo, C Sissi, et al.
Tumori
|
May 7, 2002
Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity
G Beggiolin, L Crippa, E Menta, et al.
Page
of 25
Search research articles
Search
Showing results (71-80 of 250) with videos related to
Sort By:
Page
of 25
Cancer Research
|
August 1, 1987
Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin
B Barbieri, F C Giuliani, T Bordoni, et al.
Anticancer Research
|
September 1, 1986
DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs
S Spadari, G Pedrali-Noy, F Focher, et al.
Journal of Medicinal Chemistry
|
April 1, 1989
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivatives
F M Arcamone, F Animati, B Barbieri, et al.
Fitoterapia
|
July 5, 2016
Phytochemistry, micromorphology and bioactivities of Ajuga chamaepitys (L.) Schreb. (Lamiaceae, Ajugoideae): Two new harpagide derivatives and an unusual iridoid glycosides pattern
A Venditti, C Frezza, F Maggi, et al.
Molecular Pharmacology
|
July 1, 1995
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives
P De Isabella, M Palumbo, C Sissi, et al.
Journal of Endocrinological Investigation
|
December 4, 2009
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters
A Di Mambro, C Giuliani, F Ammannati, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
May 14, 2020
How is small bowel permeability in endometriosis patients? a case control pilot study
D ViganĂ³, F Zara, S Pinto, et al.
Journal of Endocrinological Investigation
|
November 13, 2007
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells
S Benvenuti, I Cellai, P Luciani, et al.
Biochemical Pharmacology
|
January 24, 1997
Physicochemical properties, cytotoxic activity and topoisomerase II inhibition of 2,3-diaza-anthracenediones
P de Isabella, M Palumbo, C Sissi, et al.
Tumori
|
May 7, 2002
Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity
G Beggiolin, L Crippa, E Menta, et al.
Page
of 25